Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $34.32 USD
Change Today +0.77 / 2.28%
Volume 509.4K
PODD On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 2:28 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert S. Sherwin M.D.

Chairman of Scientific Advisory Board, Insulet Corporation
AgeTotal Calculated CompensationThis person is connected to 44 board members in 3 different organizations across 4 different industries.

See Board Relationships
----

Background*

Mr. Robert S. Sherwin, MD is the CNH Long Professor of Medicine, Section of Endocrinology at Yale University School of Medicine. Mr. Sherwin also serves as Director of the Diabetes Endocrinology Research Center and the General Clinical Research Center, Yale University, New Haven, Connecticut. He was subsequently appointed to the faculty of Yale University School of Medicine in 1974. Mr. Sherwin serves as Chairman & Member of the Scientific Advisory Board of Insulet Corporation. ...

Read Full Background

Corporate Headquarters*

600 Technology Park Drive
Billerica, Massachusetts 01821

United States

Phone: 978-600-7000
Fax: 978-600-0120

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education 1967
Albert Einstein College of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PODD:US $34.32 USD +0.77

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kevin R. Sayer Chief Executive Officer, President and Director
DexCom, Inc.
$325.0K
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$2.0M
Philip Bowman Chief Executive Officer and Executive Director
Smiths Group plc
1.5M GBP
Christophe Weber Chief Executive Officer, President and Representative Director
Takeda Pharmaceutical Company Limited
¥230.0M
Kim D. Blickenstaff Chief Executive Officer, President and Director
Tandem Diabetes Care, Inc.
$532.7K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INSULET CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.